Search - tctmd.com

Displaying 1 - 20 of 27

Sort: Relevancy | Date

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for April 2025

Caitlin E. Cox

April 30, 2025

News Opinion Editor's Corner ACC 2025

What’s Going to Be Hot at ACC 2025?

Michael O'Riordan

March 26, 2025

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for December 2024

Caitlin E. Cox

December 31, 2024

News Daily News

‘Functional’ SYNTAX Score May Hone PCI, CABG Choices in Multivessel Disease

Michael O'Riordan

September 13, 2023

News Conference News EuroPCR 2023

Meta-analysis Finds No Excess Mortality Risk With Coronary Revascularization

Michael O'Riordan

May 19, 2023

News Conference News ACC 2022

No Difference in 1-Year QoL Between FFR-Guided PCI and CABG: FAME-3

Michael O'Riordan

April 13, 2022

News Conference News ACC 2022

FLAVOUR: FFR as Good as IVUS for Intermediate Coronary Stenoses

Michael O'Riordan

April 06, 2022

News Conference News ACC 2022

What’s Going to Be Hot at ACC 2022, In Person or Virtual

Shelley Wood

March 28, 2022

News Opinion Editor's Corner

Glancing Back, Looking Forward: Lasting Lessons for Years to Come

Shelley Wood

December 27, 2021

News Features

FFR’s Future: Negative Trials Spur Debate Over Technology’s Role

Michael O'Riordan

December 23, 2021

News Daily News

TCTMD’s Top 10 Most Popular Stories for November 2021

Shelley Wood

November 30, 2021

News Conference News EuroPCR 2021

Elective Revascularization, Better Long-term Survival: Meta-analysis

Michael O'Riordan

May 18, 2021

News Daily News

Popularity vs Reputation: Content Matters for #CardioTwitter

L.A. McKeown

March 23, 2021

News Daily News

In ISCHEMIA, Stable CAD Treatment Effect Hinged on MI Definition

Michael O'Riordan

December 11, 2020

News Daily News

Plaque Burden, Not Coronary Stenosis, Linked to Future Events in Stable CAD

Michael O'Riordan

December 07, 2020

News Conference News EuroPCR 2020

No Survival Benefit With Revascularization in Stable CAD, Meta-analysis Confirms

Michael O'Riordan

June 26, 2020

News Opinion Editor's Corner

ISCHEMIA Questions? Some Answers From David Maron

Shelley Wood

December 09, 2019

News Daily News

ISCHEMIA Patients: High Rates of Severe-to-Moderate Ischemia, Multivessel CAD

Michael O'Riordan

March 01, 2019

News Daily News

ORBITA Redux: Lancet Correspondence Takes Talk of the Sham-Controlled PCI Trial to Further Heights

Michael O'Riordan

July 10, 2018

Advertisement

TCTMD’s Top 10 Most Popular Stories for April 2025

What’s Going to Be Hot at ACC 2025?

TCTMD’s Top 10 Most Popular Stories for December 2024

‘Functional’ SYNTAX Score May Hone PCI, CABG Choices in Multivessel Disease

Meta-analysis Finds No Excess Mortality Risk With Coronary Revascularization

No Difference in 1-Year QoL Between FFR-Guided PCI and CABG: FAME-3

FLAVOUR: FFR as Good as IVUS for Intermediate Coronary Stenoses

What’s Going to Be Hot at ACC 2022, In Person or Virtual

Glancing Back, Looking Forward: Lasting Lessons for Years to Come

FFR’s Future: Negative Trials Spur Debate Over Technology’s Role

TCTMD’s Top 10 Most Popular Stories for November 2021

Elective Revascularization, Better Long-term Survival: Meta-analysis

Popularity vs Reputation: Content Matters for #CardioTwitter

In ISCHEMIA, Stable CAD Treatment Effect Hinged on MI Definition

Plaque Burden, Not Coronary Stenosis, Linked to Future Events in Stable CAD

No Survival Benefit With Revascularization in Stable CAD, Meta-analysis Confirms

ISCHEMIA Questions? Some Answers From David Maron

ISCHEMIA Patients: High Rates of Severe-to-Moderate Ischemia, Multivessel CAD

ORBITA Redux: Lancet Correspondence Takes Talk of the Sham-Controlled PCI Trial to Further Heights

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content